Hernia Repair Devices Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Hernia Mesh, Hernia Fixation Devices), By Procedure Type (Open Surgery, Laparoscopic Surgery), By Surgery Type (Inguinal Hernia, Umbilical Hernia, Incisional Hernia, Femoral Hernia, Others), by region, and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 6.45 Billion
CAGR (2026-2031)	3.17%
Fastest Growing Segment	Hernia Mesh Devices
Largest Market	North America
Market Size (2031)	USD 7.78 Billion

Market Overview

The Global Hernia Repair Devices Market will grow from USD 6.45 Billion in 2025 to USD 7.78 Billion by 2031 at a 3.17% CAGR. Hernia repair devices encompass a specialized range of surgical meshes and fixation systems designed to reconstruct or reinforce tissue wall defects during herniorrhaphy procedures. The market is primarily driven by the expanding geriatric population and increasing obesity rates, both of which significantly elevate the physiological susceptibility to abdominal wall weaknesses. Furthermore, the sustained shift toward minimally invasive laparoscopic and robotic-assisted surgeries accelerates the demand for specialized biologic and synthetic repair materials.

A significant challenge impeding market expansion is the ongoing scrutiny regarding post-operative complications and litigation associated with synthetic mesh implants, which can delay regulatory approvals and affect clinical adoption. Despite these regulatory hurdles, procedural volume remains robust in established healthcare systems, sustaining the demand for repair devices. According to the Royal College of Surgeons of England, in 2024, hernia repair continued to be one of the most common surgical procedures with over 120,000 operations performed annually in the United Kingdom.

Key Market Drivers

Technological advancements in robotic and laparoscopic surgeries are significantly reshaping the market by offering enhanced precision and faster recovery times. This shift toward minimally invasive platforms is particularly evident in the surge of general surgery volumes, where robotic systems are becoming the standard for complex abdominal wall reconstructions. According to Intuitive Surgical, January 2025, in the 'Preliminary Fourth Quarter and Full Year 2024 Results', worldwide da Vinci procedures grew approximately 17% in 2024, a rise largely attributed to the expansion of general surgery applications in the United States. This technological adoption supports a massive procedural burden, as hernia repair remains a cornerstone of surgical workload. According to TELA Bio, in 2025, hernia repairs represent one of the most common surgeries in the United States with approximately 1.5 million procedures performed annually.

Innovation in biologic and bioabsorbable mesh materials is simultaneously driving market momentum as surgeons seek to mitigate chronic inflammatory responses associated with permanent synthetics. These advanced matrices are designed to facilitate natural tissue remodeling and minimize the risk of post-surgical recurrence, addressing a critical clinical need for high-risk patient cohorts. The growing commercial success of such hybrid scaffolds highlights this decisive trend toward materials that support anatomy preservation. According to Fierce Biotech, December 2025, in the article 'Tela Bio sues BD over hernia mesh monopoly claims', TELA Bio reported full-year 2024 revenue of $69.3 million, marking a 19% increase driven by demand for its OviTex reinforced biologic mesh portfolio.

Download Free Sample Report

Key Market Challenges

The ongoing scrutiny regarding post-operative complications and litigation associated with synthetic mesh implants creates a substantial barrier to market entry and expansion for the Global Hernia Repair Devices Market. Manufacturers now face rigorous clinical evidence requirements to mitigate liability risks, which significantly inflates research and development costs while extending approval timelines. This hostile regulatory environment forces companies to divert capital toward legal defense and compliance rather than innovation, causing a deceleration in the commercialization of next-generation herniorrhaphy devices.

The direct consequence of these regulatory pressures is a marked reduction in regional market attractiveness and product availability. According to MedTech Europe, in 2024, the percentage of large medical device manufacturers selecting the European Union as their first launch geography dropped by 33 percent due to the complexities of meeting heightened safety and performance requirements. This trend demonstrates how regulatory stringency, driven by safety concerns, effectively limits the volume of new products reaching established healthcare systems. By stifling the introduction of advanced technologies, the market experiences slower revenue turnover and reduced procedural adoption rates for novel repair materials.

Key Market Trends

The Expansion of Hernia Repair Procedures into Ambulatory Surgical Centers is fundamentally altering the site-of-care landscape for abdominal wall reconstruction. Payors and healthcare systems are aggressively incentivizing the migration of intermediate-acuity surgeries, such as inguinal and ventral hernia repairs, from hospital inpatient departments to outpatient facilities to optimize cost-efficiency and procedural turnover. This structural transition is supported by substantial revenue growth in dedicated surgical arms of major health systems, confirming the commercial viability of this shift. According to ASC News, February 2025, in the article 'Tenet Healthcare Reports Strong ASC Growth, Plans Continued Expansion in 2025', Tenet’s United Surgical Partners International (USPI) division reported full-year 2024 net operating revenues of $4.5 billion, a 15.4% increase largely driven by the volume shift of high-acuity cases to ambulatory settings.

Concurrently, there is a Surging Demand for Biologic and Biosynthetic Mesh Implants, particularly those utilizing advanced polymer technologies like poly-4-hydroxybutyrate (P4HB). Unlike traditional biologics often reserved for complex reconstruction in high-risk patients, newer biosynthetic platforms are penetrating the market for routine defects, such as umbilical hernias, offering a resorbable scaffold that provides temporary strength without leaving permanent foreign material. This adoption is evidenced by the commercial scaling of next-generation absorbable portfolios targeting broader patient populations. According to Xtalks, April 2025, in the article 'BD Rolls Out Industry-First Bioabsorbable Hernia Mesh for Umbilical Hernias', Becton, Dickinson and Company launched a new P4HB patch and announced that its bioabsorbable Phasix Mesh portfolio has now surpassed 385,000 implants globally.

Segmental Insights

The hernia mesh devices segment represents the fastest-growing category within the global hernia repair devices market. This expansion is primarily driven by the widespread clinical preference for tension-free repair techniques, which demonstrate significantly lower recurrence rates compared to traditional suture-based methods. Additionally, the introduction of biologic and partially absorbable materials has improved patient compatibility and safety profiles. Continued oversight by regulatory authorities, such as the US Food and Drug Administration, ensures the reliability of these implantable devices, further reinforcing surgeon confidence and supporting the sustained demand for mesh-based solutions in high-volume surgical procedures.

Regional Insights

North America leads the Global Hernia Repair Devices Market, supported by established healthcare infrastructure and substantial healthcare spending. The region’s dominance is reinforced by the strong presence of major medical device manufacturers and the early adoption of advanced surgical techniques, such as robotic and minimally invasive repairs. Additionally, comprehensive reimbursement frameworks make these procedures accessible to a broad patient base. Rising hernia incidence, driven by an aging demographic and lifestyle factors, further sustains demand. The U.S. Food and Drug Administration (FDA) supports this growth through established pathways for approving innovative device technologies.

Recent Developments

• In September 2025, Medtronic plc released positive results from its Enable Hernia Repair clinical study, which evaluated the safety and effectiveness of the Hugo robotic-assisted surgery system. The prospective, multi-center trial involved nearly two hundred patients undergoing inguinal and ventral hernia repairs and successfully met its primary performance endpoints. Data presented at a major medical congress demonstrated a high rate of surgical success with no conversions to open or laparoscopic methods for the inguinal cohort. These findings supported the efficacy of the company’s robotic platform in general surgery, highlighting its potential to enhance clinical outcomes in complex hernia procedures.
• In April 2025, W. L. Gore & Associates announced the commercial availability of the GORE SYNECOR Preperitoneal Biomaterial across markets in Europe, the Middle East, and South Africa. This hybrid synthetic mesh was developed to provide permanent strength for hernia repairs while facilitating tissue ingrowth through its unique bioabsorbable component. The device was designed for ease of handling during minimally invasive operations, such as robotic and laparoscopic surgeries, as well as open repairs. The regional launch followed the receipt of regulatory certification and represented a significant expansion of the company’s hernia repair capabilities in these international territories.
• In April 2024, TELA Bio, Inc. announced the commercial launch of its OviTex IHR Reinforced Tissue Matrix in the United States, expanding its portfolio of soft-tissue reconstruction solutions. This specific device was engineered to address the clinical requirements of laparoscopic and robotic-assisted inguinal hernia repair procedures. The product featured a design compatible with trocars to facilitate minimally invasive techniques and was made available in multiple configurations, including anatomically shaped three- or four-layer versions. The offering utilized the company's proprietary reinforced biologic technology, which integrates layers of ovine rumen with polymer suture to ensure structural integrity while minimizing the permanent synthetic footprint in the patient.
• In April 2024, Deep Blue Medical Advances expanded its specialized surgical offerings with the launch of the T-Line Mini, a compact version of its proprietary hernia mesh technology. This new device was specifically tailored for the repair of umbilical hernias and smaller abdominal wall defects, addressing a distinct need for appropriately sized implants in soft tissue surgery. The introduction allowed surgeons to apply the company's novel mesh extension technology, which is designed to distribute tension and prevent fixation failure, to a broader range of common procedures. This development underscored the company's commitment to building a comprehensive platform of solutions for reducing hernia recurrence.

Key Market Players

• Medtronic Plc.
• Ethicon Inc.
• Beckton Dickinson & Co,
• Atrium
• W. L. Gore & Associates, Inc.
• LifeCell International Pvt. Ltd.
• B. Braun SE
• Baxter International Inc.
• Cook Medical Inc
• Herniamesh S.r.l.

By Product Type	By Procedure Type	By Surgery Type	By Region
Hernia Mesh Hernia Fixation Devices	Open Surgery Laparoscopic Surgery	Inguinal Hernia Umbilical Hernia Incisional Hernia Femoral Hernia Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Hernia Repair Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Hernia Repair Devices Market, By Product Type:

• Hernia Mesh
• Hernia Fixation Devices

• Hernia Repair Devices Market, By Procedure Type:

• Open Surgery
• Laparoscopic Surgery

• Hernia Repair Devices Market, By Surgery Type:

• Inguinal Hernia
• Umbilical Hernia
• Incisional Hernia
• Femoral Hernia
• Others

• Hernia Repair Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE